Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Lv, Yong Tao ^a   Zhang, Yun ^b   Liu, Min ^a   Qiuwaxi, Jia na ti ^b   Ashwood, Paul ^c   Cho, Sungho Charles ^d   Huan, Ying ^a   Ge, Ru Cun ^a   Chen, Xing Wang ^a   Wang, Zhao Jing ^b   Kim, Byung Jo ^e   Hu, Xiang ^b  

^a Shandong Jiaotong Hospital   (China)

^b Shenzhen Beike Cell Engineering Institute   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Korea University   (South Korea)

Author keywords

Autism; Cell transplantation; Cord blood mononuclear cell; Umbilical cord derived mesenchymal stem cell

Indexed keywords

ABERRANT BEHAVIOR CHECKLIST; ARTICLE; AUTISM; CHILD; CHILDHOOD AUTISM RATING SCALE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMAN; HUMAN CELL; INJECTION; LABORATORY TEST; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; OPEN STUDY; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; RATING SCALE; REHABILITATION CARE; SCORING SYSTEM;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UMBILICAL CORD;

EID: 84883077674     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-196     Document Type: Article

References (49)

1. Theoharides TC, Kempuraj D, Redwood L. Autism: an emerging 'neuroimmune disorder' in search of therapy. Expert Opin Pharmacother 2009, 10(13):2127-2143. 10.1517/14656560903107789, 19640207.
2. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, Leboyer M, Gillberg C, Bourgeron T. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 2010, 26(8):363-372. 10.1016/j.tig.2010.05.007, 20609491.
3. Mitka M. Rising autism rates still pose a mystery. JAMA 2010, 303(7):602. 10.1001/jama.2010.113, 20159865.
4. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006, 29(7):349-358. 10.1016/j.tins.2006.05.010, 16808981.
5. Bradstreet JJ, Smith S, Baral M, Rossignol DA. Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 2010, 15(1):15-32.
6. Warren Z, Veenstra-VanderWeele J, Stone W, Bruzek JL, Nahmias AS, Foss-Feig JH, Jerome RN, Krishnaswami S, Sathe NA, Glasser AM, Surawicz T, McPheeters ML. Therapies for Children with Autism Spectrum Disorders 2011, Rockville (MD): Agency for Healthcare Research and Quality (US), Apr. Report No.: 11-EHC029-EF.
7. McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J. A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 2011, 127(5):e1312-e1321. 10.1542/peds.2011-0427, 21464191.
8. Ospina MB, Krebs Seida J, Clark B, Karkhaneh M, Hartling L, Tjosvold L, Vandermeer B, Smith V. Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One 2008, 3(11):e3755. 10.1371/journal.pone.0003755, 2582449, 19015734.
9. Peterson DA. Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem. J Clin Invest 2004, 114(3):312-314. 484988, 15286794.
10. Park DH, Borlongan CV, Willing AE, Eve DJ, Cruz LE, Sanberg CD, Chung YG, Sanberg PR. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant 2009, 18(9):985-998. 10.3727/096368909X471279, 19523333.
11. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med 2010, 8:75-80. 10.1186/1479-5876-8-75, 2922090, 20682053.
12. Yang WZ, Zhang Y, Wu F, Zhang M, Cho SC, Li CZ, Li SH, Shu GJ, Sheng YX, Zhao N, Tang Y, Jiang S, Jiang S, Gandjian M, Ichim TE, Hu X. Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia. J Transl Med 2011, 9:65. 10.1186/1479-5876-9-65, 3112442, 21575250.
13. De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 2012, 12(5):574-591. 10.2174/156652412800619950, 22515979.
14. Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011, 164(1):1-8. 10.1111/j.1365-2249.2011.04327.x, 3087902, 21466544.
15. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, Washington (DC): American Psychiatric Association, 4, American Psychiatric Association.
16. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010, 62(8):2467-2475. 10.1002/art.27548, 20506343.
17. Rellini E, Tortolani D, Trillo S, Carbone S, Montecchi F. Childhood autism rating scale (CARS) and autism behavior checklist (ABC) correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord 2004, 34(6):703-708. 10.1007/s10803-004-5290-2, 15679189.
18. Guy W. ECDEU Assessment Manual for Psychopharmacology 1976, Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
19. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985, 89(5):485-491.
20. Malone RP, Delaney MA, Hyman SB, Cater JR. Ziprasidone in adolescents with autism: an open-label pilot study. J Child Adolesc Psychopharmacol 2007, 17(6):779-790. 10.1089/cap.2006.0126, 18315450.
21. Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012, 26(3):383-392. 10.1016/j.bbi.2011.08.007, 3418145, 21906670.
22. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57(1):67-81. 10.1002/ana.20315, 15546155.
23. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011, 5(1):40-45.
24. Ashwood P, Corbett BA, Kantor A, Schulman H, Van de Water J, Amaral DG. In search of cellular immunophenotypes in the blood of children with autism. PLoS One 2011, 6(5):e19299. 10.1371/journal.pone.0019299, 3087757, 21573236.
25. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J. Altered T cell responses in children with autism. Brain Behav Immun 2011, 25(5):840-849. 10.1016/j.bbi.2010.09.002, 3039713, 20833247.
26. Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Sharp FR, Ashwood P. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 2009, 23(1):124-133. 10.1016/j.bbi.2008.08.001, 2636576, 18762240.
27. Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 2006, 178(1-2):149-155.
28. Vojdani A, O'Bryan T, Green JA, Mccandless J, Woeller KN, Vojdani E, Nourian AA, Cooper EL. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci 2004, 7(3):151-161. 10.1080/10284150400004155, 15526989.
29. Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 2006, 80(1):1-15. 10.1189/jlb.1205707, 16698940.
30. Kaplan JM, Youd ME, Lodie TA. Immunomodulatory activity of mesenchymal stem cells. Curr Stem Cell Res Ther 2011, 6(4):297-316. 10.2174/157488811797904353, 21190531.
31. Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007, 262(5):509-525. 10.1111/j.1365-2796.2007.01844.x, 17949362.
32. Soleymaninejadian E, Pramanik K, Samadian E. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol 2012, 67(1):1-8. 10.1111/j.1600-0897.2011.01069.x, 21951555.
33. Che N, Li X, Zhou S, Liu R, Shi D, Lu L, Sun L. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol 2012, 274(1-2):46-53.
34. Cutler AJ, Limbani V, Girdlestone J, Navarrete CV. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol 2010, 185(11):6617-6623. 10.4049/jimmunol.1002239, 20980628.
35. Chen K, Wang D, Du WT, Han ZB, Ren H, Chi Y, Yang SG, Zhu D, Bayard F, Han ZC. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol 2010, 135(3):448-458. 10.1016/j.clim.2010.01.015, 20207200.
36. Liang J, Gu F, Wang H, Hua B, Hou Y, Shi S, Lu L, Sun L. Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 2010, 6(8):486-489. 10.1038/nrrheum.2010.80, 20517294.
37. Wilcox J, Tsuang MT, Ledger E, Algeo J, Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology 2002, 46(1):13-16. 10.1159/000063570, 12571427.
38. Gupta SK, Ratnam BV. Cerebral perfusion abnormalities in children with autism and mental retardation: a segmental quantitative SPECT study. Indian Pediatr 2009, 46(2):161-164.
39. Burroni L, Orsi A, Monti L, Hayek Y, Rocchi R, Vattimo AG. Regional cerebral blood flow in childhood autism: a SPET study with SPM evaluation. Nucl Med Commun 2008, 29(2):150-156. 10.1097/MNM.0b013e3282f1bb8e, 18094637.
40. Critchley HD, Daly EM, Bullmore ET, Williams SC, Van Amelsvoort T, Robertson DM, Rowe A, Phillips M, McAlonan G, Howlin P, Murphy DG. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000, 123(Pt 11):2203-2212.
41. Ichim TE, Solano F, Glenn E, Morales F, Smith L, Zabrecky G, Riordan NH. Stem cell therapy for autism. J Transl Med 2007, 5:30. 10.1186/1479-5876-5-30, 1914111, 17597540.
42. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967. 10.1126/science.275.5302.964, 9020076.
43. Hildbrand P, Cirulli V, Prinsen RC, Smith KA, Torbett BE, Salomon DR, Crisa L. The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 2004, 104(7):2010-2019. 10.1182/blood-2003-12-4219, 15213103.
44. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ. Numerous growth factors, cytokines, and chemokines are secreted by human CD34 (+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001, 97(10):3075-3085. 10.1182/blood.V97.10.3075, 11342433.
45. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004, 114(3):330-338. 484977, 15286799.
46. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 91(8):1017-1026.
47. Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?. J Biomed Biotechnol 2012, 2012:480289. 3303614, 22496609.
48. Munarriz R, Bennett L, Goldstein I. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002, 347(5):314-321. 10.1056/NEJMoa013171, 12151468.
49. Ma JH, Guo YQ, Jia MX, Li X, Liu J. Reliability and validity of the Chinese version of the aberrant behavior checklist (ABC) in children with autism. Chin Ment Health J 2011, 25(1):14-19.